03/06/2014 - 9:35am

Grand View Research projects that the global mHealth market will reach well in excess of $20 billion from a base of $2 billion in 2012, as part of a recent market research study.

03/06/2014 - 8:40am

McNeil Consumer Healthcare on Wednesday introduced a new form to the Zyrtec portfolio of allergy-relief products — an oral, dissolvable tablet.

03/05/2014 - 12:05pm

Dr. Reddy's Labs announced the launch of moxifloxacin hydrochloride tablets — the generic version of Avelox tablets — in 400-mg form.

03/05/2014 - 10:10am

Most people who abuse prescription opioid drugs get them for free from a friend or relative — but those at highest risk of overdose are as likely to get them from a doctor’s prescription, Centers for Disease Control researchers reported Monday in a research letter, “Sources of Prescription Opioid Pain Relievers by Frequency of Past-Year Nonmedical Use: United States, 2008-2011,” in the Journal of the American Medical Association Internal Medicine.

03/05/2014 - 9:34am

Upsher-Smith Labs introduced a new educational program created for patients living with seizure clusters, as well as their families and friends.

03/04/2014 - 11:04am

Eden Sulzer, director of Cardinal Health’s Women in Pharmacy initiative, on Tuesday will discuss the unprecedented opportunity female pharmacists have to assume community pharmacy ownership roles during a panel discussion at the 2014 International Women's Day Forum, taking place at the United Nations.

03/04/2014 - 10:19am

Teva Pharmaceutical Industries announced that it received approval for generic Evista (raloxifene) tablets, 60-mg, in the United States.

03/03/2014 - 3:55pm

Last week, more than 30 organizations — including the American Medical Association, Infectious Diseases Society of America and Pew Charitable Trusts — urged Congressional leaders to strengthen the labeling requirements for drugs approved under the proposed Antibiotic Development to Advance Patient Treatment Act of 2013 (ADAPT Act) limited population approval pathway, which will streamline regulatory approval for antibiotics.

03/03/2014 - 1:48pm

An international team led by researchers at the Broad Institute and Massachusetts General Hospital has identified mutations in a gene that can reduce the risk of developing Type 2 diabetes, even in people who have such risk factors as obesity and old age, the group announced Sunday.